INDEPENDENT PHARMACY NETWORKS WILL BE STIMULATED BY ANTITRUST SETTLEMENTS, ex-PCS CEO JOHNSON SAYS; MANUFACTURERS, WHOLESALERS WILL OWN PHARMACIES
Increased integration of retail pharmacy into the healthcare delivery system will be a long-term result of the antitrust pharmaceutical pricing suits, former PCS Chairman Robert Johnson said April 21 at the Food Market Institute's Supermarket Pharmacy Conference in San Diego. Johnson now heads R.C. Johnson & Associates.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth